ARTICLE | Clinical News
ProCervix: Phase II data
February 1, 2016 8:00 AM UTC
Top-line data from 232 evaluable patients ages 25-50 infected with HPV types 16 and/or 18 in the double-blind, European Phase II RHEIA-VAC trial showed that 2 intradermal vaccinations of GTL001 given ...